{
  "slug": "serna-bio",
  "name": "Serna Bio",
  "yc_id": 22617,
  "batch": "Winter 2021",
  "website": "http://serna.bio",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T00:58:04.929528",
    "website": "http://serna.bio",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 4388.23,
      "final_url": "https://www.serna.bio/",
      "redirected": true,
      "checked_at": "2025-10-17T00:58:09.317775"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "serna.bio",
      "error": "Whois command returned no output"
    },
    "social_links": {
      "twitter": "https://x.com/serna_bio",
      "linkedin": "https://www.linkedin.com/company/sernabio/",
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": true,
      "x_frame_options": true,
      "x_content_type_options": false,
      "x_xss_protection": false,
      "referrer_policy": false,
      "security_score": 50,
      "server": "cloudflare"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:26:05.917920",
  "phase1_complete": true,
  "phase2_complete": true,
  "phase3_complete": true,
  "phase4_complete": true,
  "phase5_complete": true,
  "geographic_data": {
    "geographic_enrichment_version": "2.0.0",
    "enriched_at": "2025-10-17T10:25:55.710961",
    "place_data": {
      "status": "not_found",
      "query": "Ontario, CA, USA; Remote",
      "methods_tried": [
        "static_db",
        "nominatim",
        "geonames"
      ]
    }
  },
  "github_data": {
    "github_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T10:25:56.912346",
    "status": "no_github_link"
  },
  "network_data": {
    "network_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T10:25:56.912375",
    "batch_network": {
      "batch": "Winter 2021",
      "total_batch_mates": 335,
      "active_batch_mates": 244,
      "batch_success_rate": 72.8,
      "notable_batch_mates": [
        {
          "name": "Stacksi",
          "slug": "stacksi",
          "status": "Acquired",
          "top_company": false,
          "one_liner": "Automated Answers to Security Questionnaires"
        },
        {
          "name": "Furmacy",
          "slug": "furmacy",
          "status": "Acquired",
          "top_company": false,
          "one_liner": "Digital e-prescribing software for veterinarians."
        },
        {
          "name": "Fountain9",
          "slug": "fountain9",
          "status": "Acquired",
          "top_company": false,
          "one_liner": "Helping food brands and retailers reduce food wastage"
        },
        {
          "name": "Zepto",
          "slug": "zepto",
          "status": "Active",
          "top_company": true,
          "one_liner": "10-Minute Grocery Delivery in India"
        },
        {
          "name": "Segments.ai",
          "slug": "segments-ai",
          "status": "Acquired",
          "top_company": false,
          "one_liner": "Build better computer vision models by building better datasets"
        },
        {
          "name": "PingPong",
          "slug": "pingpong",
          "status": "Acquired",
          "top_company": false,
          "one_liner": "Video messaging app for remote teams."
        },
        {
          "name": "ClipDrop",
          "slug": "clipdrop",
          "status": "Acquired",
          "top_company": false,
          "one_liner": "Turn regular mobile photos into professional product visuals"
        },
        {
          "name": "Avenue",
          "slug": "avenue",
          "status": "Acquired",
          "top_company": false,
          "one_liner": "Observability platform for operations teams"
        },
        {
          "name": "Flok",
          "slug": "flok",
          "status": "Acquired",
          "top_company": false,
          "one_liner": "End to end company retreat planning"
        },
        {
          "name": "HyperGlue",
          "slug": "hyperglue",
          "status": "Acquired",
          "top_company": false,
          "one_liner": "Business intelligence on text"
        }
      ],
      "batch_size": 336
    },
    "industry_network": {
      "industries": [
        "Healthcare",
        "Therapeutics"
      ],
      "total_industry_peers": 642,
      "active_industry_peers": 502,
      "direct_competitors": [
        {
          "name": "Sigma Genetics",
          "slug": "sigma-genetics",
          "status": "Active",
          "batch": "Winter 2017",
          "one_liner": "Sigma Genetics is a biotechnology company that is building\u2026"
        },
        {
          "name": "Forever Labs",
          "slug": "forever-labs",
          "status": "Active",
          "batch": "Summer 2017",
          "one_liner": "We bank your stem cells to help you live healthier, longer."
        },
        {
          "name": "Nectome",
          "slug": "nectome",
          "status": "Active",
          "batch": "Winter 2018",
          "one_liner": "Building a way to preserve long-term memories."
        },
        {
          "name": "Tradewind BioScience",
          "slug": "tradewind-bioscience",
          "status": "Active",
          "batch": "Winter 2018",
          "one_liner": "Tradewind translates scientific insight into innovative ways of\u2026"
        },
        {
          "name": "Persephone Biosciences",
          "slug": "persephone-biosciences",
          "status": "Active",
          "batch": "Winter 2018",
          "one_liner": "We are using the gut microbiome to end cancer. "
        },
        {
          "name": "Reverie Labs",
          "slug": "reverie-labs",
          "status": "Inactive",
          "batch": "Winter 2018",
          "one_liner": " Engineering next-generation, brain-penetrant cancer therapies."
        },
        {
          "name": "Mind Emulation Foundation",
          "slug": "mind-emulation-foundation",
          "status": "Active",
          "batch": "Winter 2018",
          "one_liner": ""
        },
        {
          "name": "Hepatx",
          "slug": "hepatx",
          "status": "Active",
          "batch": "Summer 2018",
          "one_liner": "Replacing organ transplant with an infusion"
        },
        {
          "name": "dNovo",
          "slug": "dnovo",
          "status": "Inactive",
          "batch": "Summer 2018",
          "one_liner": "The cure for hair loss."
        },
        {
          "name": "Perception Biosystems",
          "slug": "perception-biosystems",
          "status": "Inactive",
          "batch": "Summer 2018",
          "one_liner": "Democratizing gene therapy by reinventing its manufacturing and\u2026"
        }
      ],
      "competitor_count": 10
    },
    "geographic_network": {
      "city": "Ontario",
      "location": "Ontario, CA, USA; Remote",
      "companies_in_city": 1,
      "active_in_city": 1,
      "nearby_companies": [
        {
          "name": "LogisticsOS",
          "slug": "logisticsos",
          "batch": "Winter 2021",
          "industry": "B2B",
          "status": "Active"
        }
      ],
      "ecosystem_density": "low"
    },
    "tech_network": {
      "status": "no_tech_data"
    },
    "similar_companies": [
      {
        "name": "Valink Therapeutics",
        "slug": "valink-therapeutics",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Active",
        "similarity_score": 8,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:2",
          "same_tech"
        ]
      },
      {
        "name": "Biodock",
        "slug": "biodock",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Active",
        "similarity_score": 8,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:2",
          "same_tech"
        ]
      },
      {
        "name": "Entelexo Biotherapeutics",
        "slug": "entelexo-biotherapeutics",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Active",
        "similarity_score": 8,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:2",
          "same_tech"
        ]
      },
      {
        "name": "Nuntius Therapeutics",
        "slug": "nuntius-therapeutics",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Active",
        "similarity_score": 8,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:2",
          "same_tech"
        ]
      },
      {
        "name": "PipeBio",
        "slug": "pipebio",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Acquired",
        "similarity_score": 8,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:2",
          "same_tech"
        ]
      },
      {
        "name": "Bristle",
        "slug": "bristle",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Active",
        "similarity_score": 6,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:1",
          "same_tech"
        ]
      },
      {
        "name": "Trestle Biotherapeutics",
        "slug": "trestle-biotherapeutics",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Active",
        "similarity_score": 6,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:1",
          "same_tech"
        ]
      },
      {
        "name": "Snazzy",
        "slug": "snazzy",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Active",
        "similarity_score": 6,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:1",
          "same_tech"
        ]
      },
      {
        "name": "Quadrant Eye",
        "slug": "quadrant-eye",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Inactive",
        "similarity_score": 6,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:1",
          "same_tech"
        ]
      },
      {
        "name": "MedMe Health",
        "slug": "medme-health",
        "batch": "Winter 2021",
        "industry": "Healthcare",
        "status": "Active",
        "similarity_score": 6,
        "similarity_reasons": [
          "same_batch",
          "shared_industries:1",
          "same_tech"
        ]
      }
    ],
    "network_metrics": {
      "total_yc_connections": 978,
      "network_density_score": 100,
      "has_strong_batch_network": true,
      "has_strong_industry_network": true,
      "has_strong_geo_network": false,
      "calculated_at": "2025-10-17T10:25:56.947088"
    }
  },
  "patent_data": {
    "patent_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T10:25:56.947104",
    "patents": {
      "status": "api_error",
      "error": "HTTP 410",
      "patent_count": 0
    }
  },
  "reviews_data": {
    "reviews_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T10:25:57.293373",
    "producthunt": {
      "status": "error",
      "error": "HTTP 403"
    },
    "g2": {
      "status": "not_implemented",
      "note": "G2 scraping requires Selenium + anti-bot bypass"
    }
  },
  "phase6_complete": true,
  "hiring_data": {
    "hiring_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T10:25:57.415696",
    "basic_info": {
      "is_hiring": false,
      "team_size": 9,
      "note": "Full job scraping not implemented - placeholder"
    }
  },
  "phase7_complete": true,
  "ai_insights": {
    "ai_insights_version": "1.0.0",
    "model_used": "claude-sonnet-4-20250514",
    "enriched_at": "2025-10-17T11:44:36.252393",
    "status": "success",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "emerging",
      "key_trends": [
        "RNA therapeutics gaining momentum after COVID mRNA vaccines",
        "Precision medicine driving demand for targeted genetic therapies",
        "Small molecule advantages over biologics in delivery and manufacturing"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Proprietary RNA-targeting small molecule platform technology with potential IP protection",
      "differentiation": "Small molecule approach to RNA modulation vs traditional biologics, potentially easier delivery and manufacturing",
      "competitive_advantages": [
        "Small molecules can cross cell membranes more easily than biologics",
        "Lower manufacturing costs compared to gene therapies"
      ],
      "competitive_vulnerabilities": [
        "Competing against well-funded RNA therapeutics companies",
        "Unproven platform technology in early stages"
      ]
    },
    "business_model": {
      "revenue_model": "Biotech licensing and partnerships",
      "scalability": "high",
      "capital_intensity": "high"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "Team size growth to 9 employees",
        "Active status since Winter 2021"
      ],
      "growth_bottlenecks": [
        "Long drug development timelines",
        "Regulatory approval requirements",
        "Need for significant capital raises"
      ]
    },
    "risk_analysis": {
      "market_risk": "medium",
      "technology_risk": "high",
      "execution_risk": "high",
      "overall_risk_score": 8,
      "key_risks": [
        "Unproven RNA-targeting small molecule platform",
        "Long development cycles typical in biotech",
        "Regulatory approval uncertainty"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Novel approach to genetic medicine",
        "Large addressable market for genetic diseases",
        "Small molecule advantages over current RNA therapies"
      ],
      "concerns": [
        "Early-stage technology with high technical risk",
        "Intense competition from established biotech companies"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Alnylam Pharmaceuticals",
        "Ionis Pharmaceuticals"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Demonstrate proof-of-concept for lead compounds",
        "Secure Series A funding for clinical development"
      ],
      "expansion_opportunities": [
        "Partner with pharma companies for specific disease areas",
        "Expand platform to additional RNA targets"
      ]
    },
    "tokens_used": {
      "input": 648,
      "output": 586,
      "total": 1234,
      "estimated_cost": 0.010734
    }
  },
  "phase8_complete": true
}